Celcuity (NASDAQ:CELC) Trading Down 0.5%

Celcuity Inc. (NASDAQ:CELC - Get Free Report)'s stock price dropped 0.5% during mid-day trading on Wednesday . The stock traded as low as $17.51 and last traded at $17.61. Approximately 373,416 shares changed hands during trading, an increase of 69% from the average daily volume of 221,577 shares. The stock had previously closed at $17.70.

Analyst Ratings Changes

A number of brokerages have weighed in on CELC. HC Wainwright restated a "buy" rating and issued a $27.00 target price on shares of Celcuity in a research note on Thursday, March 28th. Needham & Company LLC reiterated a "buy" rating and set a $24.00 target price on shares of Celcuity in a research report on Friday, April 12th. Craig Hallum increased their price target on shares of Celcuity from $20.00 to $25.00 and gave the stock a "buy" rating in a report on Thursday, March 28th. Finally, Stifel Nicolaus started coverage on shares of Celcuity in a report on Thursday, February 22nd. They set a "buy" rating and a $40.00 price objective for the company.

Celcuity Price Performance

The firm has a market capitalization of $536.22 million, a P/E ratio of -6.55 and a beta of 0.87. The business's 50-day simple moving average is $18.05 and its 200 day simple moving average is $15.32. The company has a quick ratio of 13.43, a current ratio of 13.43 and a debt-to-equity ratio of 0.26.

Celcuity (NASDAQ:CELC - Get Free Report) last posted its quarterly earnings results on Wednesday, March 27th. The company reported ($0.65) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.71) by $0.06. Sell-side analysts forecast that Celcuity Inc. will post -2.93 earnings per share for the current year.

Institutional Trading of Celcuity

A number of institutional investors have recently modified their holdings of the company. Commodore Capital LP increased its position in Celcuity by 3.6% during the 4th quarter. Commodore Capital LP now owns 1,754,704 shares of the company's stock valued at $25,566,000 after purchasing an additional 60,563 shares during the period. Perceptive Advisors LLC purchased a new position in shares of Celcuity during the fourth quarter valued at about $21,583,000. Trust Point Inc. bought a new position in Celcuity in the fourth quarter worth about $297,000. Pale Fire Capital SE lifted its holdings in Celcuity by 38.4% in the fourth quarter. Pale Fire Capital SE now owns 14,409 shares of the company's stock worth $210,000 after buying an additional 4,000 shares during the period. Finally, SG Americas Securities LLC bought a new stake in Celcuity during the 4th quarter valued at approximately $139,000. 63.33% of the stock is currently owned by hedge funds and other institutional investors.

About Celcuity

Celcuity Inc, a clinical stage biotechnology company, focuses on the development of targeted therapies for the treatment of various solid tumors in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therapy for the treatment.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.